Monday, 8 June 2020

Global Anti-viral drugs Market 2020 – Investment Strategy, Outlook and Key Development till 2023

Market Scenario:
The rising cases of viral disease is identified to boost the global anti-viral drugs market growth. The inadequacy of dietary nutrition in people, due to increase in consumption of high calorie and low fibrous food is creating favourable condition for virus to invade human body. Hence, the need for anti-viral drugs are surging as viral infections prevail. The growing incidences of HIV and other sexually-transmitted diseases are also boosting the sales number of anti-viral drugs, hence, anticipated to prompt the anti-viral drug market growth.
The increase in cases of drug resistance is propelling extensive research and developmental undertakings for launching more effective anti-viral drugs. Additionally, the stringency in drug approval stages are taking care of the quality of drugs in the pipeline. New product launches are gaining traction for revenue generation for the anti-viral drugs market. The application of anti-viral drugs in other diseases like, bird flu, and others is also likely to prompt the global anti-viral drug market growth.
The expiry of patents for certain blockbuster anti-viral drug are stimulating generic drug competition in the anti-viral drug market. This is deepening the competitive scenario of the global anti-viral drug market over the assessment period.
However, adverse effects of anti-viral drugs and high price of anti-viral drugs can hinder the anti-viral drugs market growth over the assessment period. 
Key Players
MRFR have enlisted some of the prominent Anti-viral drugs Market Companies operating in the anti-viral drugs market. They are; Hoffmann-La Roche Ltd., Johnson & Johnson, Merck & Co. Inc., Gilead Sciences Inc., Cipla Inc. GlaxoSmithKline Plc, Novartis International AG, Abbott Laboratories, and  Astra Zeneca AB. 
Market Segmentation:
Global anti-viral drugs market has been segmented on the basis of on the basis of application, which comprises hepatitis, HIV/AIDS, herpes, influenza and others. On the basis of mechanism of action; market is segmented into nucleotide polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors and others.
Regional Analysis:
Depending on geographic region, anti-viral drugs market is segmented into four key regions: America, Europe, Asia Pacific, and Middle East & Africa. Globally, America is the largest market for anti-viral drugs with Europe tied for the second space. Asia Pacific region is expected to be fastest growing region in anti-viral drugs market. 
Posted by at No comments:

Bioinformatics Market 2020 Global Trend, Segmentation and Opportunities, Forecast 2023

Market scenario:
The Global Bioinformatics Market report from Market Research Future (MRFR) is expected to exhibit a CAGR of 19.8% over the forecast period from 2016 to 2022, according to a new research. The global bioinformatics trends and industry is mainly driven by the growing demand in developing countries in enhancing their healthcare sector and making advanced healthcare modalities available to patients.
The growing demand for electronic healthcare data storage is likely to be a major driver for the global bioinformatics market. The reliance on manual and paper-based documentation of healthcare procedures has resulted in unmanageable volumes of healthcare information, which can make it difficult to locate individual patients and their medical history. Electronic healthcare records, which are but the first step of the bioinformatics market, have already become widely popular in developed countries due to the benefits they present in terms of consistent data storage over the long term and ease in acquiring specific details at any given time. The growing demand for e-prescriptions and online pharmacies is likely to further the cause of the bioinformatics market over the forecast period, as strong bioinformatics networks are needed to operate and manage e-prescriptions and the related documentation.
The growing demand for strong data storage facilities in medical research is also likely to be a major driver for the global bioinformatics market. Bioinformatics plays a key role in genetic studies, in which it helps track details regarding multiple genes and their multifarious associations with the indicators being studied in the respective trial. The growing dependence on genetic studies in cancer research is likely to be a major driver for the global bioinformatics market over the forecast period, as cancer research has received strong government backing across the world. Other medical research applications are also likely to make use of bioinformatics systems on a large scale in the coming years, leading to steady growth of the global bioinformatics market over the forecast period.
Study Objectives of Bioinformatics Market:
  • To provide detail analysis of the market structure along with forecast for the next 7 years about various segments and sub-segments of the global bioinformatics market.
  • To provide insights about factors affecting the market growth.
  • To analyze the market based on price analysis, supply chain analysis, Porters Five Force analysis etc.
  • To provide past and estimated future revenue of the market’s  segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific, and Middle East & Africa.
  • To provide country level analysis of the market with respect to the current market size and future growth prospective.
  • To provide country level analysis of the market for segments by drug application, by technology, by sector and services and its sub-segments.
  • To provide overview about key players and their strategic profiling in the market; comprehensively analyzing their core competencies and drawing a competitive landscape of the market.
  • To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global Bioinformatics market.
Intended Audience
  • Bioinformatics service providers
  • Bioinformatics manufacturers
  • Research and development (R&D) companies
  • Government research laboratories
  • Government and independent regulatory authorities
Segmentation:
The global bioinformatics market is segmented on the basis of application, service, sector, and region in the MRFR report in order to provide a comprehensive coverage of all important factors related to the market’s growth prospects over the forecast period.
The bioinformatics market has been segmented on the basis of application into genomics, chemoinformatics, drug design, transcriptomics, molecular phylogenetics, proteomics, metabolomics, DNA sequences, and others. Increasing interest in genetic studies is likely to be a major driver for the global bioinformatics market over the forecast period.
On the basis of services and technology, the global bioinformatics market is segmented into data warehousing, sequence analysis, sequence manipulation, and others.
Key Players for Bioinformatics Market:                                                        
  • Agilent Technologies,
  • Illumina, Inc.,
  • QIAGEN N. V, and Thermo Fisher Scientific Inc.,
  • Dassault Systèmes,
  • QIAGEN and others.   
Regional Analysis:
The global bioinformatics market is segmented by region into the Americas, Europe, Asia Pacific, and the Middle East and Africa. The global bioinformatics market is dominated by the Americas and Europe in terms of region due to the presence of strong telecommunications infrastructure in these regions to support advanced bioinformatics processes. The presence of a strong wireless internet and other telecommunication features is crucial for a bioinformatics system to function productively. This has actually been one of the key factors that has held back the bioinformatics market in underdeveloped regions.
In April 2019, researchers from UCLA announced a plan to develop a system that would allow scientists in developing countries to use cloud computing and big data analytics to accelerate the development of the bioinformatics field in their own countries. Efforts such as these are the result of the growing awareness of the disparity in terms of telecommunications infrastructure between developed and developing countries.
Asia Pacific is likely to exhibit the fastest growth over the forecast period due to the increasing efforts from governments in the region to incorporate powerful bioinformatics programs into the day-to-day functioning of their country’s healthcare sector.
Posted by at No comments:

Sunday, 7 June 2020

Global Microbiology Testing Market 2020 Business Insights & Deep Analysis to 2023 by World’s Top 10 Key Players

Overview

The Global Microbiology Testing Market Size is expected to register 10.4% CAGR and is anticipated to reach USD 5409.1 6 Million by 2023. Microbiology testing services help to lower the potential damage risk by microbes and to ensure that the microbiology quality of the products is maintained. The microbial testing technique includes chemical, biological, biochemical, or molecular methods to quantify and identify microbes.
Technological advancements, rising cases of infectious diseases, surveillance programs for disease control, increasing stringency of standards, weakness of traditional laboratory techniques are the major drivers propelling market growth. However, erroneous results and high cost of reagents and instruments may constrain the growth of the market.
Market Dynamics
Technological advancements are expected to drive the growth of the market. For instance, according to the data published by the National Centre for Health Statistics in 2017, there were around 9,272 cases of tuberculosis infectious disease. Additionally, rising cases of infectious diseases, surveillance programs for disease control, increasing stringency of standards, weakness of traditional laboratory techniques are likely to support market growth. On the other hand, erroneous results and high cost of reagents and instruments are anticipated to hamper the market growth.
Segmentation
The global market has been segmented into product type, application, and end user. 
Based on type, the global market has been segmented into instruments, chemicals & reagents, consumables & accessories, and others. The instruments segment accounted for a market value of USD 954.9 million in 2016.
Based on application, the global market has been segmented into gastrointestinal infections, respiratory infections, urinary tract infections, sexually transmitted infections, and others.
Based on end user, the global market has been segmented into hospital associate laboratory, independent laboratory, and academic and research institutes.
Key Players
The prominent players in the global microbiology testing market are, Beckman Coulter, Inc. (a subsidiary of Danaher Corp), BioMérieux SA, Thermo Fisher Scientific Inc., Cepheid (a subsidiary of Danaher), and F. Hoffmann-La Roche Ltd.
Some of the key strategies followed by the players operating in the global microbiology testing market were innovation, product development, acquisition, and expansion.
Regional Analysis
The global microbiology testing market, based on region, is segmented into North Americas, Europe, Asia-Pacific, and the Middle East & Africa.
North America is estimated to dominate the global microbiology testing market during the forecast period. This can be attributed to the rapid adoption of advanced products and techniques. The European market for microbiology testing is expected to be the second-largest during the forecast period. Increasing innovation and changing laboratory practices is expected to boost the growth of the market in this region.
Asia-Pacific is estimated to be the fastest-growing market due to increasing funding for R&D, developing healthcare infrastructure, growing awareness about microbiology testing, government initiatives to improve public health, and growing investments by major players. Moreover, in the region, South Korea accounted for a market share of 9.2% in 2016.
The market in the Middle East & Africa is expected to witness steady growth due to limited access to healthcare facilities, lack of knowledge of new microbiology testing techniques, less funding R&D, and limited availability to equipment.
Posted by at No comments:

Dental Consumables Market Overview with Detailed Analysis, Competitive landscape, Forecast to 2024

Market Scenario:
Acknowledging the developments and accruals the market is enjoying currently, Market Research Future (MRFR) in its recently published study report asserts that the global dental consumables market will be valued at USD 28,345 MN by 2024, registering approximately 7 % CAGR during the forecast period (2016 – 2024). 
The global market of dental consumables, including US dental consumables market is growing pervasively mainly due to the technological advancements that took place in the dental industry. Although the integration of technology & consumables in dental practices goes back to decades, the uptake of consumables has been increasing over the past few years, and so is increasing the growth of the dental consumables market. Furthermore, factors such as the wide adoption of dental consumables along with the increasing geriatric populace, prevailing dental disorders and surgeries are driving the market growth.
The growing spread of the dentistry field has been a massive driver for the global dental consumables market over the forecast period. The field of dentistry has evolved rapidly in modern times to encompass several specialties such as orthodontics, prosthodontics, and endodontics. This has led to a growing demand for a number of procedures in the dentistry field as well as for the consumables used in these procedures. The rapid evolution of the dentistry field is likely to remain a major driver for the global dental consumables market over the forecast period. The growing insistence on single-use consumables, in order to ensure the sterility and safety of the component in each procedure, is also likely to drive the demand from the dental consumables market over the forecast period. While the field of dentistry has grown to encompass several sub-specialties, the instruments and equipment used by the various fields are largely similar, leading to a steady growth in demand from the dental consumables market.
The growing demand for dental procedures due to the growing prevalence of conditions such as plaque and dental caries is likely to remain a major driver for the global dental consumables market over the forecast period. Growing consumption of chocolate and candy among the younger generation has led to a growing prevalence of dental problems around the world, leading to a growing demand for dental procedures and thus for dental consumables. The growing disposable income of consumers in emerging regions is also likely to be a key driver for the global dental consumables market over the forecast period.
On the other hand, these dental consumables are costlier especially in developing and underdeveloped nations which in turn, is hampering the market growth in these regions restricting the uptake of consumables. Also, the operational complexities of these consumables may restrain the growth of this market.
Competitive Analysis:
Leading players in the global dental consumables market include Septodont, Straumann, KERR Corporation, EnvisionTEC, American Orthodontics, Dentsply Sirona, Nobel Biocare, Planmeca OY, Patterson Dental, GC Orthodontics, Henry Schein, and 3M.
In March 2019, the NHS announced a planned price increase for dental procedures from April 1. The price increase covers minor dental procedures as well as major operations such as root canal. This could have a key impact on the dental consumables market in Europe over the forecast period.
Segmentation:
The global dental consumables market is segmented on the basis of type and region.
By type, the global dental consumables market is segmented into dental implants, dental restorative materials, dental prosthetics, dental regenerative materials, and others. The dental implants segment is likely to remain the top earner in the global dental consumables market over the forecast period due to the growing demand for dental implants for health as well as cosmetic reasons.
Regional Analysis:
The global dental consumables market is segmented by region into Americas, Europe, Asia Pacific, and the Middle East and Africa.
Europe holds the largest share in the global dental consumables market by region and is likely to remain the leading revenue generator in the market over the forecast period due to the growing demand for advanced dental procedures in the region and the widespread availability of dental healthcare facilities. The growing scope of the healthcare sector in the region is likely to enable smooth growth of the dental consumables market over the forecast period.
Asia Pacific is likely to exhibit the fastest growth in the global dental consumables market over the forecast period due to the growing disposable income of consumers in the region and the growing prevalence of dental conditions requiring complicated operations and surgical procedures.
The Americas is also likely to hold on to a major share in the global dental consumables market due to the strong presence of several leading players in the dental consumables industry and the high spending power of the geriatric demographic in the region, which plays a key role in the growth of dental services and equipment.
Posted by at No comments:

Global Clear Aligners Market 2020 Industry Analysis, Share, Growth, Trends and Forecast 2025


Market Research Future (MRFR) collected data on several factors including implications of covid-19 impact on microbiome sequencing services market and demographic challenges, showed how it could move forward in the coming years.
Global Clear Aligners Market size is expected to register 20.80% CAGR and is anticipated to reach USD 7019.96 Million by 2025. 
Clear aligners are an alternative to traditional braces and are designed to help arrange teeth into their proper position. Similar to braces, clear aligners use a gradual force to control the tooth movement, but without metal wires or brackets. The aligners are made of a durable plastic material and are fabricated to fit each individual's mouth.
Global clear aligners market share is driven by the increase in youth and geriatric population, growing dental service organizations, increase in dental procedures, and the rising prevalence of dental diseases. However, factors such as complications of clear aligners and the gray market for dental distribution are expected to restrict market growth during the forecast period.
Impact of Covid-19 Global Clear Aligners Market
The COVID-19 epidemic has been straining healthcare workflow across the globe. The disease has forced various industries to temporary shut its doors including many healthcare subdomains. Clear aligners have been one of the major markets that has been negatively impacted by COVID-19. The production for clear aligners has been disrupted across the globe. COVID-19 has forced various dentists to slash their services and staff resulting in delay in large number of appointments which is leading to increasing complications. Also, various events with respect to dental and clear aligners have been suspended. These events were supposed to be conducted in accordance to increase awareness and improve revenue for clear aligners. The company exocad, recently acquired by Align Technology, announced that its Insights 2020 event would be delayed to September 2020. Furthermore, the third congress of the European Aligner Society, which was supposed to be held in Malta from 19 to 21 March 2020, has been shifted to November 2020. The aim of this event was to introduce advances in technologies and techniques in aligner orthodontics and also major opportunity for various large manufacturers to enter into strategic alliances.
The company Align Technology, one of the leading players, accounts for more than 70% of the market share across the globe is also facing challenges in generating revenue due to COVID-19. In March, the company’s stock fell down by 20%. The analysis shows that the major reason for this was the lockdown in China where the company generated 8% of its entire revenue. The outcome of this lockdown is expected a $30 million to $35 million hit on revenue for the first quarter alone.
We have observed the massive impact of novel coronavirus on people’s lives over the last five months. It has also impacted various industries across the globe, eventually affecting the global economy. Some industries have experienced negative growth, whereas some industries have experienced tremendous demand and have generated massive revenues in this period. Covid 19 Impact on Clear Aligners market is the one of the positive impact sector on global industry
Clear Aligners Market Dynamics
The increasing expenditure on healthcare has minimized human efforts and increased the quality of patient care services. Moreover, the development of advanced technology in the healthcare industry has improved and provided many facilities to patients as per their needs, driving the growth of the global clear aligners market. For instance, according to the Official Portal of the UAE Government, approximately AED 3.83 billion (USD 1.00 billion) was allocated to the healthcare sector in 2015 in the UAE. Following the same course, AED 4.2 billion (USD 1.099 billion) was allocated for the healthcare and protection society in 2017.
Moreover, the growing youth and geriatric population, increasing prevalence of dental diseases, and technological advancements in dentistry are also expected to provide favorable conditions to the growth of the market during the forecast period.
However, the limitations of clear aligners and grey market for dental distribution are creating hurdles in the growth of the global clear aligners market.
Segmentation
The global clear aligners market has been segmented into product type, age, distribution channel, and region. 
Based on product type, the global market has been segmented into hard, medium, and soft.
Based on age, the global market has been divided into teenager and adult. The teenager segment is likely to hold the maximum share in the global market with a value of 1427.98 million in 2018.
Based on distribution channel, the global market has been divided into direct sales and distributor.
Clear Aligners Market Key Players
The prominent players in the global clear aligners market are Align Technology, Inc., Dentsply Sirona, Institut Straumann AG, Clarus Company, Danaher Corporation, and 3M.
Some of the key strategies followed by the players operating in the global clear aligners market were innovation, product development, acquisition, and expansion.
Regional Analysis
Global clear aligners market, based on region, is segmented into– the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
The Americas is expected to command the largest market share due to aesthetic dentistry and other vast specialized services present in countries of North America. Additionally, the rising health expenditure per person and increasing demand for advanced technologies are driving the growth of the clear aligners market in these countries. Additionally, the presence of a large number of noticeable players in this region is the major driving factor of the market in the Americas.
Europe accounts for the second-largest market, majorly due to the soaring demand for dental procedures. Additionally, the increasing incidences of oral problems, vast application of technologically advanced techniques, and the growing importance of treatment, planning, and diagnosis in implant dentistry in European countries are driving the clear aligners market in Europe.
Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/report/covid-19-impact-clear-aligners-market
Asia-Pacific with lots of opportunities and continuously growing economies is expected to be the fastest-growing region. Furthermore, recent developments in healthcare and improving economies and disposable income per individual are fueling market growth.
The Middle East & Africa is expected to grow significantly during the forecast period due to the increasing cases of dental abnormalities and the demand for better teeth-related treatments in the region.


Posted by at No comments:

Liquid Biopsy Market Overview with Detailed Analysis, Competitive landscape, Forecast to 2022

Market Insights:
Liquid biopsy overcomes these problems of tissue biopsy by using biomarkers present in samples such as blood, urine etc. and thus is a comparatively non-invasive technique. Liquid biopsy also provides greater information about the sample which is real time. The real time data can be used for monitoring and thereby determining the treatment for diseases such as cancer. The greater sensitivity of tissue biopsy coupled with the development of sophisticated detectors with extremely low detection rates have enabled the early detection of diseases which is the holy grail of cancer.
Biopsy involves extracting a sample of tissue and testing it for the presence of diseases especially cancer. Traditional tissue biopsy is a painful technique and also has a high rate of false results. Moreover the technique is costly, time consuming and not applicable for extracting samples such as those close to vital organs such as heart.
Segmentation:
Global Liquid Biopsy market has been segmented on the basis of biomarker type which comprises of circulating tumor cells (Ctcs), circulating tumor DNA (Ctdna), extracellular vesicles (Evs) and other biomarker. On the basis of application; market is segmented into cancer therapeutic application, reproductive health, and other therapeutic application. On the basis of sample; market is segmented into blood, urine and others. On the basis of end-users; market is segmented into hospitals and laboratories, academic and research centres and others.
Major Players
  • Guardant Health, Inc.,
  • Trovagene, Inc.,
  • RainDance Technologies, Inc.,
  • Agena Bioscience Inc. Inc.,
  • Admera Health,
  • Biocept, Inc.,
  • Circulogene Theranostics,
  • Inivata Ltd.,
  • SAGA Diagnostics AB,
  • Exosome Diagnostics and others.
Drivers
The market drivers for the liquid biopsy market are rising rates of cancer, growing investment in research and development, collaborations between companies and public organizations, rise in geriatric population, rising expenditure on health etc. The factors which are inhibiting the growth of the market includes the prohibitive costs associated with liquid biopsy and the differential awareness and availability between developing and the developed world. However, not all cancer patients benefit from early detection as some cancer types such as brain cancer and prostate cancer may lie dormant for many years. Further liquid biopsy is not all non-invasive as can be seen in case of using spinal fluid as sample.
Also the technique is not applicable to all types of cancer as some cancers such as brain cancer and prostate cancer may lie dormant for many years, and thus are either undetectable or detected very late which robs liquid biopsy of its advantages. Further liquid biopsy is not all non-invasive as can be seen in case of using spinal fluid as sample.
Regional Analysis:
Depending on geographic region, Liquid biopsy market is segmented into four key regions: Americas, Europe, Asia Pacific, and Middle East & Africa. Globally developed countries led by North America is the largest market for Liquid biopsy. Europe is the second-largest market for liquid biopsy. The developing regions market such as Asia pacific region and Middle East & Africa however is rising much faster.
Key findings
  • Circulating tumor cells (CTCs) segment dominates both in terms of market share as well as revenues, contributing approx. 55.48% of the revenue share of the liquid biopsy market.
  • On the basis of the therapeutic application, the segment for Cancer will reflect the highest growth potential, with over 82.83% of the market share by revenues. However, the urine sample segment is anticipated to witness noticeable growth.
  • The market for liquid biopsy is dominated by North America and Europe and this trend will continue. Asia-Pacific market is the fastest growing market and is expected to grow at a CAGR of 29.7% during forecasted period
Posted by at No comments:

Global Cranial Fixation and Stabilization Market 2020 – Investment Strategy, Outlook and Key Development till 2025

The Global Cranial Fixation and Stabilization devices Market is expected to reach USD 2.29 billion by 2025 at a steady CAGR of 8.90%.
Cranial fixation and stabilization is required during all surgeries and procedures involving the head. With new medical procedures increasingly relying on finesse and minimal invasion, the stability of the head is critical.
According to the WHO, over 6.8 million people die of neurological conditions each year. Consequently, the need for a deeper understanding of neurological conditions and the development of innovative surgical procedures are expected to drive the demand for cranial fixation and stabilization equipment.
The increasing use of biocompatible materials and synergetic technological growth along with medical advances are key to the development of the market, which is projected to expand in tandem with the progress of medical science and equipment.
Market USP
Critical need for the most advanced technologies and equipment when operating on the head and neck
Market Drivers
  • Increased global spending on healthcare
  • Large-scale technological advancements in healthcare equipment
  • Development of new and specialized surgical procedures to treat various neurological and head/neck trauma cases
  • Standardization of healthcare practices and procedures globally
  • Critical need for head/neck stabilization during surgery
  • Symbiotic growth of the healthcare and technology industries
  • Emphasis on reducing patient mortality

  • Increase in prevalence of neurological conditions such as epilepsy, stroke, neuroinfections, and traumatic injuries

  • Surge in the number of road accidents

Market Restraints
  • Stringent regulations regarding classification of cranial fixation and stabilization equipment as class II and class III medical devices
  • Different regulatory standards across the globe affecting imports and exports
Segmentation
By Category
  • Cranial Fixation Systems: Used for fastening bones after fractures, fastening skin to heal trauma, and for increasing cranial integrity post-surgery. Required for trauma cases, which make up the majority of brain surgeries, resulting in the segment accounting for the larger market share.
  • Cranial Stabilization Systems: Used to stabilize the head during invasive procedures. Required for intensive and delicate brain surgery procedures.
By Product
  • Meshes: Used for reconstructive procedures where part of the skull has been damaged.
  • Skull Clamps: Used to hold the head firmly in place for surgery.
  • Flap Tube Clamps: Used to attach cranial bones to the cranium in a singular motion.
  • Horseshoe Headrests: Used to stabilize the head by supporting the neck so head movement is still possible.
  • Plates: Used to replace skull parts that are too damaged to be repaired.
  • Screws: Used to attach fractured/broken cranial bones.
  • Accessories: Used to aid in the stabilization of the head by complementing other cranial stabilization systems.
By Type
  • Resorbable: These cranial fixation systems are eventually broken down and absorbed by the body. Resorbable equipment is more expensive but the segment accounts for a smaller market share.
  • Non-Resorbable: Cranial fixation systems that are either permanently attached to the patient’s cranium or require follow-up surgery for removal. Used extensively in developing countries due to their lower costs.
By End User
  • Hospitals: Cranial stabilization systems are almost entirely used by hospitals, while the majority of the cranial fixation systems also find application in this segment.
  • Ambulatory Surgical Centers: These establishments mostly deal with trauma cases and injuries that require immediate attention. However, these centers command disproportionate revenues due to the nature of their services.
  • Others: This segment covers on-site trauma and emergency surgeries.
By Region
  • Americas
  • Asia-Pacific
  • Europe
  • Middle East & Africa
Regional Analysis
  • Americas: With a massive 55% of the market share concentrated in North America alone, the market in the Americas is currently leading the global cranial fixation and stabilization market.
  • Asia-Pacific: This is the fastest-growing regional market due to the aggressive economic growth in the region, the increased spending on healthcare, and presence of a large patient pool of neurological disorders and head traumas requiring surgery.
  • Europe: Currently the second-largest, the European market is expected to register steady growth. Healthcare implementation in Europe occurs at the behest of the governments and not companies, making this a secure and stable market. However, the manufacture of medical equipment is privatized and, therefore, subject to stringent regulations. To fast track the regulatory process, the EU has created a single body for all member countries, thereby directly benefiting medium- and small-scale manufacturers.
  • Middle East & Africa: With limited medical infrastructure the regional market currently accounts for the least share of the global market. However, a young population, industrialization and urbanization, and increasing awareness of new medical procedures are expected to result in the eventual growth of the market.
Competitive Analysis
Key Players
  • Johnson & Johnson (US)
  • Stryker (US)
  • Ostomed (UK)
  • KLS Martin Group (Germany)
  • Medtronic (US)
  • Integra LifeSciences Corporation (US)
  • Braun Melsungen AG (Germany)
  • Changzhou Huida (China)
  • DePuy Synthes (US)
  • Evonos (Germany)
  • Jeil Medical (South Korea)
  • Medicon (Germany)
  • Micromar (Brazil)
  • NEOS Surgery (Spain)
  • Pro Med Instruments (Germany)
  • Zimmer Biomet (US)
Posted by at No comments:
Subscribe to: Posts (Atom)